ursodeoxycholic acid has been researched along with Cirrhosis in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (3.33) | 18.2507 |
| 2000's | 10 (33.33) | 29.6817 |
| 2010's | 10 (33.33) | 24.3611 |
| 2020's | 9 (30.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mayo, MJ | 1 |
| Dotan, M; Fried, S; Har-Zahav, A; Shamir, R; Waisbourd-Zinman, O; Wells, RG | 1 |
| Aishima, S; Eguchi, Y; Higurashi, T; Honda, A; Honda, Y; Hosono, K; Hyogo, H; Imajo, K; Iwaki, M; Kage, M; Kasai, Y; Kato, S; Kawaguchi, T; Kawanaka, M; Kessoku, T; Kobayashi, N; Kobayashi, T; Nakajima, A; Nogami, A; Ogawa, Y; Oyamada, S; Ozaki, A; Saito, S; Shinoda, S; Sumida, Y; Takahashi, H; Takahashi, K; Tanaka, K; Torimura, T; Usuda, H; Wada, K; Yamamoto, A; Yoneda, M | 1 |
| Chai, J; Fu, L; Peng, S; Tao, L; Wang, H; Zhang, J; Zhang, X; Zhao, N; Zhou, Z | 1 |
| Corpechot, C | 1 |
| Gao, L; He, X; Leung, PSC; Rojas, M; Yang, Y | 1 |
| Bowlus, C; Gao, L; Gershwin, ME; He, X; Leung, PSC; Wang, L; Woo, E; Yang, G | 1 |
| Bloks, VW; de Boer, JF; de Vries, HD; Doestzada, M; Dombrowicz, D; Fu, J; Haas, JT; Hoogerland, JA; Hovingh, MV; Kloosterhuis, NJ; Koehorst, M; Kuipers, F; La Rose, AM; Li, R; Mulder, NL; Palmiotti, A; Staels, B; van de Sluis, B; Westerterp, M; Wolters, JC | 1 |
| Caldez, MJ; Hunziker, W; Kaldis, P; Kausalya, PJ; Mohamed Ali, S; Ong, AGM; Van Hul, N; Woo, WL; Xu, J; Xu, S | 1 |
| Bernuzzi, F; Carbone, M; Gershwin, ME; Invernizzi, P; Malinverno, F; Mousa, HS; Ronca, V | 1 |
| Aguesse, A; Boursier, J; Chaigneau, J; Coué, M; Croyal, M; Falewée, J; Fizanne, L; Ouguerram, K; Tesse, A | 1 |
| Khan, MN; Middleton, JP; Niccum, M; Syed, S; Vergales, BD | 1 |
| Chang, HY; Choi, J; Kim, JK; Lee, DK; Lee, JI; Lee, KS; Lee, SY | 1 |
| Eller, K; Fickert, P; Frauscher, B; Grahammer, F; Huber, TB; Kirsch, AH; Krones, E; Marschall, HU; Pollheimer, MJ; Racedo, S; Rosenkranz, AR; Ståhlman, M; Trauner, M; Wagner, K; Wahlström, A | 1 |
| Dienes, HP; Frenzel, C; Galle, PR; Herkel, J; Kanzler, S; Kasper, HU; Lohse, AW; Lüth, S; Schramm, C | 1 |
| Grenier, N; Harper, L; Lamireau, T; Lavrand, F; Le Bail, B; Notz, A | 1 |
| Alex, G; Clarnette, T; Rosenbaum, J | 1 |
| Bruemmer, K; Carlson, CG; Curtis, H; Gatti, F; Graham, KM; Malnassy, G; Millman, G; Sesti, J; Singh, R; Stefanski, C | 1 |
| Bonder, A; Bonis, PA; Kaplan, MM; Ruthazer, R | 1 |
| Álvarez Ferre, J; González Jiménez, E; Schmidt Río-Valle, J | 1 |
| Akcam, M; Büyükyavuz, BI; Duman, L; Koroglu, M; Tepeli, H | 1 |
| Angulo, P; Burgart, L; Colin, P; Harrison, ME; Heathcote, EJ; Jorgensen, R; Kowdley, KV; Lindor, KD; Lymp, JF | 1 |
| Yamada, G | 1 |
| Lesterhuis, W; Puylaert, JB; van Buuren, HR; Van Der Werf, SD; Van Eijck, CH; Vleggaar, FP; Willemien Erkelens, G; Zondervan, PE | 1 |
| Imamura, M; Ishida, H; Nakajima, H; Nezu, S; Takahashi, S; Tanaka, A; Yasui, H | 1 |
| García-Buey, L; Gisbert, JP; Gómez-Dominguez, E; Jones, EA; Mendoza, J; Moreno-Otero, R; Trapero, M | 1 |
| Färkkilä, M; Kärkkäinen, P; Karvonen, AL; Niemelä, O; Nurmi, H; Rautiainen, H | 1 |
| Benkerrou, M; de Graeff-Meeder, BR; Fischer, A; Haddad, E; Patey, N; Spliet, WG; Wulffraat, NM | 1 |
| Hahn, EG; Schuppan, D | 1 |
| Blendis, LM; Cameron, RG; Haber, JA; Katz, GG; Neuman, MG | 1 |
7 review(s) available for ursodeoxycholic acid and Cirrhosis
| Article | Year |
|---|---|
Mechanisms and molecules: What are the treatment targets for primary biliary cholangitis?
Topics: Cholagogues and Choleretics; Cholangitis; Cholestasis; Fibrosis; Humans; Inflammation; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid | 2022 |
Noninvasive Evaluation of Fibrosis and Portal Hypertension in Primary Biliary Cholangitis.
Topics: Fibrosis; Humans; Hypertension, Portal; Liver Cirrhosis; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid | 2022 |
Mechanism-based target therapy in primary biliary cholangitis: opportunities before liver cirrhosis?
Topics: Animals; Cholangitis; Cholestasis; Fibrosis; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid | 2023 |
Clinical Management of Primary Biliary Cholangitis-Strategies and Evolving Trends.
Topics: Animals; Bile Acids and Salts; Biomarkers; Chenodeoxycholic Acid; Combined Modality Therapy; Disease Management; Disease Progression; Disease Susceptibility; Fibrosis; Humans; Immunotherapy; Liver Cirrhosis, Biliary; Liver Transplantation; Molecular Targeted Therapy; Severity of Illness Index; Symptom Assessment; Treatment Outcome; Ursodeoxycholic Acid | 2020 |
From pathogenesis to novel therapies in the treatment of primary biliary cholangitis.
Topics: Autoimmunity; Bile Ducts, Intrahepatic; Chenodeoxycholic Acid; Cholangitis; Fibrosis; Humans; Immunotherapy; Liver; Liver Cirrhosis, Biliary; Molecular Targeted Therapy; Ursodeoxycholic Acid; Ustekinumab | 2017 |
[Fatty liver and its clinical management in obese adolescents].
Topics: Adiponectin; Adolescent; Apoptosis; Biomarkers; Chemokines; Disease Progression; Fatty Liver; Fibrosis; Hepatocytes; Humans; Hypertriglyceridemia; Insulin Resistance; Kupffer Cells; Liver Cirrhosis; Liver Transplantation; Metformin; Models, Biological; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative Stress; Ursodeoxycholic Acid; Vitamin E | 2011 |
[Clinical aspects of type-C cirrhosis of liver--diagnosis, clinical course, treatment and prognosis].
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Cysteine; Disease Progression; Drug Combinations; Drug Therapy, Combination; Fibrosis; Glycine; Hepatitis C, Chronic; Humans; Interferons; Liver; Liver Cirrhosis; Liver Neoplasms; Oleanolic Acid; Prognosis; Ribavirin; Risk; Ursodeoxycholic Acid | 2004 |
3 trial(s) available for ursodeoxycholic acid and Cirrhosis
| Article | Year |
|---|---|
Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Cholagogues and Choleretics; Disease Progression; Double-Blind Method; Fatty Liver; Fibrosis; Humans; Liver; Necrosis; Ursodeoxycholic Acid | 2004 |
Serological markers for monitoring disease progression in noncirrhotic primary biliary cirrhosis on ursodeoxycholic acid therapy.
Topics: Anti-Inflammatory Agents; Aspartate Aminotransferases; Bile Acids and Salts; Biomarkers; Biopsy; Budesonide; Cholagogues and Choleretics; Disease Progression; Drug Therapy, Combination; Fibrosis; Humans; Hyaluronic Acid; Liver; Liver Cirrhosis, Biliary; Liver Function Tests; Peptide Fragments; Predictive Value of Tests; Procollagen; Prospective Studies; ROC Curve; Ursodeoxycholic Acid | 2008 |
An electron microscopic and morphometric study of ursodeoxycholic effect in primary biliary cirrhosis.
Topics: Adult; Aged; Apoptosis; Cell Count; Cholagogues and Choleretics; Collagen; Double-Blind Method; Female; Fibrosis; Hepatocytes; Humans; Liver; Liver Cirrhosis, Biliary; Male; Microscopy, Electron; Middle Aged; Ursodeoxycholic Acid | 2002 |
20 other study(ies) available for ursodeoxycholic acid and Cirrhosis
| Article | Year |
|---|---|
Periductal bile acid exposure causes cholangiocyte injury and fibrosis.
Topics: Animals; Bile Acids and Salts; Bile Ducts; Bile Ducts, Extrahepatic; Fibrosis; Glycochenodeoxycholic Acid; Mice; Ursodeoxycholic Acid | 2022 |
Association of Serum and Fecal Bile Acid Patterns With Liver Fibrosis in Biopsy-Proven Nonalcoholic Fatty Liver Disease: An Observational Study.
Topics: Bile Acids and Salts; Biopsy; Fibrosis; Humans; Liver Cirrhosis; Non-alcoholic Fatty Liver Disease; Ursodeoxycholic Acid | 2022 |
Fluorofenidone ameliorates cholestasis and fibrosis by inhibiting hepatic Erk/-Egr-1 signaling and Tgfβ1/Smad pathway in mice.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Anti-Inflammatory Agents; Aspartate Aminotransferases; Bile Acids and Salts; Cholestasis; Fibrosis; Inflammation; Interleukin-6; Liver Cirrhosis; Male; Mice; Mice, Inbred C57BL; Pyridones; Tumor Necrosis Factor-alpha; Ursodeoxycholic Acid | 2022 |
Cholangiopathy and Biliary Fibrosis in Cyp2c70-Deficient Mice Are Fully Reversed by Ursodeoxycholic Acid.
Topics: Animals; Bile Acids and Salts; Biliary Tract Diseases; Cholangitis; Cholic Acids; Cytochrome P-450 Enzyme System; Female; Fibrosis; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Ursodeoxycholic Acid | 2021 |
Protective Functions of ZO-2/Tjp2 Expressed in Hepatocytes and Cholangiocytes Against Liver Injury and Cholestasis.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B, Member 11; Bile Acids and Salts; Bile Canaliculi; Chemical and Drug Induced Liver Injury; Cholagogues and Choleretics; Cholestasis; Cholic Acid; Claudin-1; Cytochrome P450 Family 2; Cytoskeletal Proteins; Epithelial Cells; Female; Fibrosis; Genetic Predisposition to Disease; Hepatocytes; Male; Membrane Proteins; Mice; Mice, Knockout; Mutation; Oxazoles; Permeability; Protective Factors; RNA, Messenger; Steroid Hydroxylases; Tight Junctions; Ursodeoxycholic Acid; Zonula Occludens-2 Protein | 2021 |
Spirulina Liquid Extract Protects against Fibrosis Related to Non-Alcoholic Steatohepatitis and Increases Ursodeoxycholic Acid.
Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents; Antioxidants; Blood Glucose; Cholesterol; Cholic Acids; Diet, Western; Dietary Supplements; Fibrosis; Gallbladder; Hypolipidemic Agents; Liver; Liver Cirrhosis; Male; Mice, Inbred C57BL; NF-kappa B; Nitric Oxide; Non-alcoholic Fatty Liver Disease; Spirulina; Superoxides; Thiobarbituric Acid Reactive Substances; Ursodeoxycholic Acid | 2019 |
Cholestasis affects enteral tolerance and prospective weight gain in the NICU.
Topics: Bilirubin; Birth Weight; Cholagogues and Choleretics; Cholestasis; Digestive System Surgical Procedures; Disease Progression; Fat Emulsions, Intravenous; Female; Fibrosis; Fish Oils; Humans; Hyperbilirubinemia; Infant; Infant Nutritional Physiological Phenomena; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Male; Parenteral Nutrition; Postoperative Complications; Prognosis; Retrospective Studies; Ursodeoxycholic Acid; Weight Gain | 2019 |
Omega-3 polyunsaturated fatty acid and ursodeoxycholic acid have an additive effect in attenuating diet-induced nonalcoholic steatohepatitis in mice.
Topics: Animals; Cholagogues and Choleretics; Diet, High-Fat; Drug Synergism; Fatty Acids, Omega-3; Fibrosis; Inflammation; Liver; Male; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Ursodeoxycholic Acid | 2014 |
NorUrsodeoxycholic acid ameliorates cholemic nephropathy in bile duct ligated mice.
Topics: Animals; Bile Acids and Salts; Cholestasis; Disease Models, Animal; Fibrosis; Kidney; Kidney Diseases; Ligation; Lipocalin-2; Male; Mice; Mice, Inbred C57BL; Nephritis, Interstitial; Ursodeoxycholic Acid | 2017 |
Characteristics and long-term prognosis of the autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome.
Topics: Adolescent; Adult; Aged; Cholangiography; Cholangitis, Sclerosing; Disease Progression; Drug Therapy, Combination; Female; Fibrosis; Follow-Up Studies; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis; Male; Middle Aged; Prognosis; Retrospective Studies; Syndrome; Ursodeoxycholic Acid; Young Adult | 2009 |
Non-surgical management of idiopathic fibrosing pancreatitis.
Topics: Biopsy; Child; Child, Preschool; Cholagogues and Choleretics; Cholangiopancreatography, Magnetic Resonance; Female; Fibrosis; Humans; Jaundice, Obstructive; Pancreatitis, Chronic; Remission, Spontaneous; Tomography, X-Ray Computed; Ursodeoxycholic Acid | 2010 |
Ursodeoxycholic acid's role in avoiding diversionary surgery in idiopathic fibrosing pancreatitis.
Topics: Child, Preschool; Cholagogues and Choleretics; Cholestasis; Diagnosis, Differential; Female; Fibrosis; Humans; Jaundice, Obstructive; Pancreatitis; Positron-Emission Tomography; Ursodeoxycholic Acid; Victoria | 2009 |
Excessive collagen accumulation in dystrophic (mdx) respiratory musculature is independent of enhanced activation of the NF-kappaB pathway.
Topics: Animals; Collagen; Diaphragm; Female; Fibrosis; Male; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Muscle, Skeletal; Muscular Dystrophies; NF-kappa B; Pyrrolidines; Respiratory Muscles; Respiratory System Agents; Signal Transduction; Thiocarbamates; Transforming Growth Factor beta1; Ursodeoxycholic Acid | 2010 |
Methotrexate in patients with primary biliary cirrhosis who respond incompletely to treatment with ursodeoxycholic acid.
Topics: Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Cholagogues and Choleretics; Colchicine; Disease Progression; Drug Therapy, Combination; Fibrosis; Humans; Immunosuppressive Agents; Liver; Liver Cirrhosis, Biliary; Liver Function Tests; Methotrexate; Treatment Failure; Ursodeoxycholic Acid | 2010 |
Percutaneous management of bile-plug syndrome: a case report.
Topics: Bile; Catheterization; Cefotaxime; Cholangiography; Cholangitis; Cholecystostomy; Combined Modality Therapy; Common Bile Duct Diseases; Cytomegalovirus Infections; Drainage; Fibrosis; Fluoroscopy; Ganciclovir; Hepatitis, Viral, Human; Hepatomegaly; Humans; Infant; Jaundice, Obstructive; Male; Radiography, Interventional; Ultrasonography; Ursodeoxycholic Acid | 2011 |
Autoimmune pancreatocholangitis: a series of ten patients.
Topics: Adult; Aged, 80 and over; Autoimmune Diseases; Cholagogues and Choleretics; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis, Sclerosing; Colonoscopy; Common Bile Duct; Diagnosis, Differential; Fibrosis; Humans; Immunosuppressive Agents; Liver; Male; Middle Aged; Pancreatic Ducts; Pancreatic Neoplasms; Pancreatitis; Tomography, X-Ray Computed; Ultrasonography, Interventional; Ursodeoxycholic Acid | 2006 |
Presence of antimitochondrial autoantibodies in patients with autoimmune hepatitis.
Topics: Animals; Anti-Inflammatory Agents; Autoantibodies; Bile Ducts; Cattle; Cholagogues and Choleretics; Female; Fibrosis; Hepatitis, Autoimmune; Humans; Liver; Male; Middle Aged; Mitochondria, Heart; Prednisolone; Ursodeoxycholic Acid | 2006 |
Transient elastography to assess hepatic fibrosis in primary biliary cirrhosis.
Topics: Adult; Aged; Alkaline Phosphatase; Antibodies, Antinuclear; Area Under Curve; Biopsy, Needle; Cholagogues and Choleretics; Elasticity Imaging Techniques; Female; Fibrosis; Humans; Liver; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; Prospective Studies; ROC Curve; Ursodeoxycholic Acid | 2008 |
Hepatic GVHD after HLA-haploidentical bone marrow transplantation in children with severe combined immunodeficiency: the effect of ursodeoxycholic acid.
Topics: Adrenal Cortex Hormones; Bile Duct Diseases; Bilirubin; Bone Marrow Transplantation; Cholagogues and Choleretics; Cyclosporine; Fibrosis; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Liver Diseases; Male; Severe Combined Immunodeficiency; Skin Diseases; Ursodeoxycholic Acid | 1997 |
Clinical studies with silymarin: fibrosis progression is the end point.
Topics: Cholagogues and Choleretics; Disease Progression; Drug Therapy, Combination; Fibrosis; Humans; Liver Cirrhosis, Biliary; Protective Agents; Retreatment; Silymarin; Ursodeoxycholic Acid | 2001 |